推薦: 檢驗(yàn)設(shè)備 | 影像設(shè)備 | 手術(shù)/急救設(shè)備 | 超聲設(shè)備 | 電子儀器 | 激光儀器 | 治療康復(fù)設(shè)備 | 病房護(hù)理設(shè)備 | 醫(yī)用光學(xué) | 冷療/冷藏設(shè)備 | 實(shí)驗(yàn)室設(shè)備 | 幻燈課件 | 臨床用藥 |
![]() |
首頁 > 美迪醫(yī)訊 > Clopidogrel Chinese market report |
Clopidogrel Chinese market report 【?2008-07-11 發(fā)布?】 美迪醫(yī)訊
Clopidogrel Chinese market reportReserach report of Chinese Clopidogrel market
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:
Format: Hardcopy and Adobe PDF
Price: US$1,500
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Brief introduction
Clopidogrel is a Thienopyridine derivative, Antiplatelet drug, developed by Sanofi-Avetnis (brand name Plavix). Global sales revenue of Plavix reached to $5.9 billion in 2005, second best-selling product in the global market.
Clopidogrel came into Chinese market in 2001, acquiring the most segment of the market of blood thinning drugs.
With the expiration of Plavix's patents in 2006, Canada company Apotex launched the generic Clopidogrel, indicating the generic market opening. Now only a domestic company in China acquiring the approval for Clopidogrel except Sanofi-Avetnis, Clopidogrel market is charming for the pharmaceutical companies.
The report presents the market scale and sales trend, market shares of different brands, region sales statistic etc for Clopidogrel. The market of blood thinning drugs in China is also presented in the report.
1、Summary
2 Different categories of blood thinning drugs
2.1 Anticoagulant Drugs
2.2 Antiplatelet drugs
2.3 Others of Anticoagulant or Antiplatelet drugs
2.4 Thrombolysis drugs
3 Sales analysis of blood thinning drugs from 2002 to 2005
3.1 Market scale and growth trend
3.2 Market share and change trend
3.2.1 Sales shares of different products of Blood Thinning Drugs
3.2.2 Sales shares of different products of Antiplatelet drugs
3.2.3 Sales shares of different products of Anticoagulant Drugs
3.2.4 Sales shares of different products of Thrombolysis drugs
3.3 sales rank of different brands (enterprises)
4 Sales anlalysis of Clopidogrel in 2005
4.1 Position of Clopidogrel in the market of blood thinning drugs
4.2 Market shares of different brands (enterprises)
4.3 Competition status of Clopidogrel in the past 4 years
4.3.1 Sales values and growth trend
4.3.2 Market shares of different strengths
4.3.3 Market shares of different enterprises
5 Sales analysis of key cities
6 Information of researh and development for blood thinning drugs in the world
6.1 Antiplatelet drugs
6.2 Anticoagulant Drugs
7 Information of researh and development in China
7.1 Domestic and import products marketed
7.2 Situation of examination and approval for Clopidogrel
本文關(guān)鍵字:
《美迪醫(yī)訊》歡迎您參與新聞投稿,業(yè)務(wù)咨詢: 美迪醫(yī)療網(wǎng)業(yè)務(wù)咨詢《上海醫(yī)療器械批發(fā)》產(chǎn)品推薦
|
合作支持:中華醫(yī)學(xué)會 | 中華醫(yī)院管理學(xué)會 | 國家食品藥品監(jiān)督管理家用護(hù)理器械商城 | 國藥勵展展覽有限責(zé)任公 | 醫(yī)學(xué)裝備協(xié)會 |
刊登廣告 | 友情鏈接 | 廣告代理商加盟 | 關(guān)于美迪 | 法律聲明 | 隱私保護(hù) | 網(wǎng)站地圖 |
把美迪網(wǎng)放進(jìn)收藏夾 把美迪醫(yī)療網(wǎng)介紹給我的朋友 給美迪醫(yī)療網(wǎng)留言
美迪醫(yī)療網(wǎng)廣告業(yè)務(wù)聯(lián)系:021-51601230 產(chǎn)品咨詢業(yè)務(wù)聯(lián)系:021-51601230 傳真:021-56532303 ![]() 互聯(lián)網(wǎng)藥品信息服務(wù)許可證:(滬)-經(jīng)營性-2009-0003 中華人民共和國電信與信息服務(wù)業(yè)務(wù)經(jīng)營許可證:(滬)B2-20090029 ![]() ![]() ![]() 公安備案號 31010602000199 醫(yī)療器械經(jīng)營許可證: 滬靜藥監(jiān)械經(jīng)營許20210003號 第二類醫(yī)療器械經(jīng)營備案憑證: 滬靜藥監(jiān)械經(jīng)營備20220042號 營業(yè)執(zhí)照:統(tǒng)一社會信用代碼91310108676284138X互聯(lián)網(wǎng)藥品信息服務(wù)資格書:(滬)-非經(jīng)營性-2023-0081 |